Friday, November 22, 2024
HomeTagsMultiStem

MultiStem

Athersys Expands IP Protection with First New Patent for SIFU Technology

Athersys, Inc , a cell therapy and regenerative medicine company developing MultiStem for critical care indications, announced that the United States Patent and Trademark Office...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics